A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab

Joseph Mikhael, Karim Belhadj-Merzoug, Cyrille Hulin, Laure Vincent, Philippe Moreau, Cristina Gasparetto, Ludek Pour, Ivan Spicka, Ravi Vij, Jeffrey Zonder, Djordje Atanackovic, Nashat Gabrail, Thomas G. Martin, Aurore Perrot, Samira Bensfia, Qilong Weng, Claire Brillac, Dorothée Semiond, Sandrine Macé, Kathryn P. CorzoXavier Leleu

Research output: Contribution to journalLetterpeer-review

40 Scopus citations
Original languageEnglish
Article number89
JournalBlood cancer journal
Issue number5
StatePublished - May 2021

Cite this